Wellington Management Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wellington Management Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-113,851	Closed	-$11.7M	–	1920
2023 Q2	$11.7M	Sell	113,851 -68,754	-38%	-$7.25M	﹤0.01%	1067
2023 Q1	$19.9M	Sell	182,605 -801,129	-81%	-$88.6M	﹤0.01%	939
2022 Q4	$112M	Sell	983,734 -1,657,115	-63%	-$138M	0.02%	502
2022 Q3	$163M	Buy	2,640,849 +1,476,491	+127%	+$103M	0.03%	412
2022 Q2	$92.9M	Buy	1,164,358 +587,279	+102%	+$55.6M	0.02%	552
2022 Q1	$60.7M	Buy	577,079 +237,849	+70%	+$23.2M	0.01%	698
2021 Q4	$36.6M	Hold	339,230	–	–	0.01%	932
2021 Q3	$37.2M	Sell	339,230 -280,491	-45%	-$29.1M	0.01%	911
2021 Q2	$58M	Sell	619,721 -220,149	-26%	-$20.3M	0.01%	778
2021 Q1	$77.3M	Sell	839,870 -3,091	-0.4%	-$261K	0.01%	687
2020 Q4	$61.7M	Buy	842,961 +320,569	+61%	+$23.8M	0.01%	709
2020 Q3	$40.6M	Buy	+522,392	New	+$35.9M	0.01%	750
2019 Q4	–	Sell	-8,114	Closed	-$221K	–	2196
2019 Q3	$221K	Sell	8,114 -2,650	-25%	-$68.5K	﹤0.01%	1982
2019 Q2	$259K	Sell	10,764 -53,485	-83%	-$1.36M	﹤0.01%	1999
2019 Q1	$1.7M	Buy	+64,249	New	+$1.52M	﹤0.01%	1659
2018 Q4	–	Sell	-89,423	Closed	-$1.75M	–	2287
2018 Q3	$1.75M	Sell	89,423 -198,633	-69%	-$3.78M	﹤0.01%	1737
2018 Q2	$4.77M	Buy	288,056 +186,710	+184%	+$2.85M	﹤0.01%	1504
2018 Q1	$1.44M	Buy	+101,346	New	+$1.5M	﹤0.01%	1820
2017 Q2	–	Sell	-49,421	Closed	-$730K	–	2355
2017 Q1	$730K	Buy	+49,421	New	+$800K	﹤0.01%	2006
2014 Q4	–	Sell	-62,700	Closed	-$770K	–	2284
2014 Q3	$770K	Buy	62,700 +30,100	+92%	+$350K	﹤0.01%	1888
2014 Q2	$516K	Sell	32,600 -97,070	-75%	-$1.39M	﹤0.01%	1957
2014 Q1	$1.96M	Buy	+129,670	New	+$1.46M	﹤0.01%	1693

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group's HZNP Position: Q3 2023 in Review

Wellington Management Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 113,851 shares — an estimated $11.7M sold.

Wellington Management Group first reported a position in HZNP in Q1 2014 and held it in 22 quarters. The position peaked at $163M in Q3 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Wellington Management Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Wellington Management Group sold 113,851 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $11.7M.
Wellington Management Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 22 quarters.
Wellington Management Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $163M in Q3 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Wellington Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.